Arkolith/Insider Trading/TRML/Form 4

Johnson Kevin Bruce

Chief Regulatory OfficerTourmaline Bio, Inc. (TRML) · full profile →Form 4 · filed Oct 28, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2025Tender(U)41K——11K
Oct 28, 2025Disposed to issuer(D)11K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 28, 2025Disposed to issuer(D)58K——0
Oct 28, 2025Disposed to issuer(D)47K——0
Oct 28, 2025Disposed to issuer(D)96K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001994710-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Tourmaline Bio, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp